Article Contents ::
- 1 Details About Generic Salt :: Guaifene
- 2 Main Medicine Class::
- 3 (GWHY-fen-ah-sin) Anti-Tuss Syrup 100 mg/5 mL Breonesin Capsules 200 mg Diabetic Tussin EX Liquid 100 mg/5 mL Duratuss-G Tablets 1200 mg Fenesin Tablets, sustained release 600 mg Gee-Gee Tablets 200 mg Genatuss Syrup 100 mg/5 mL GG-Cen Capsules 200 mg Glyate Syrup 100 mg/5 mL Glycotuss Tablets 100 mg Glytuss Tablets 200 mg GuiaCough CF Liquid 12.5 mg GuiaCough PE Liquid 100 mg Guiafenex LA Tablets, extended release 600 mg Guiatuss Syrup 100 mg/5 mL Humibid LA Tablets, sustained release 600 mg Humibid Sprinkle Capsules, sustained release 300 mg Hytuss Tablets 100 mg Hytuss 2x Capsules 200 mg Liquibid Tablets, sustained release 600 mg Monafed Tablets, sustained release 600 mg Muco-Fen-LA Tablets, sustained release 600 mg Mytussin Syrup 100 mg/5 mL Naldecon Senior EX Liquid 200 mg/5 mL Organidin NR Tablets 200 mg Liquid 100 mg/5 mL Pneumomist Tablets, sustained release 600 mg Respa-GF Tablets, sustained release 600 mg Robitussin Syrup 100 mg/5 mL Scot-tussin Expectorant Syrup 100 mg/5 mL Sinumist-SR Capsulets Tablets, sustained release 600 mg Siltussin SA Syrup 100 mg/5 mL Touro Ex Caplets, sustained release 600 mg Tussin Syrup 100 mg/5 mL Tusibron Syrup 100 mg/5 mL Uni-tussin Syrup 100 mg/5 mL alminil Expectorant Benylin E Class: Expectorant
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Guaifene
Main Medicine Class::
(GWHY-fen-ah-sin)
Anti-Tuss
Syrup
100 mg/5 mL
Breonesin
Capsules
200 mg
Diabetic Tussin EX
Liquid
100 mg/5 mL
Duratuss-G
Tablets
1200 mg
Fenesin
Tablets, sustained release
600 mg
Gee-Gee
Tablets
200 mg
Genatuss
Syrup
100 mg/5 mL
GG-Cen
Capsules
200 mg
Glyate
Syrup
100 mg/5 mL
Glycotuss
Tablets
100 mg
Glytuss
Tablets
200 mg
GuiaCough CF
Liquid
12.5 mg
GuiaCough PE
Liquid
100 mg
Guiafenex LA
Tablets, extended release
600 mg
Guiatuss
Syrup
100 mg/5 mL
Humibid LA
Tablets, sustained release
600 mg
Humibid Sprinkle
Capsules, sustained release
300 mg
Hytuss
Tablets
100 mg
Hytuss 2x
Capsules
200 mg
Liquibid
Tablets, sustained release
600 mg
Monafed
Tablets, sustained release
600 mg
Muco-Fen-LA
Tablets, sustained release
600 mg
Mytussin
Syrup
100 mg/5 mL
Naldecon Senior EX
Liquid
200 mg/5 mL
Organidin NR
Tablets
200 mg
Liquid
100 mg/5 mL
Pneumomist
Tablets, sustained release
600 mg
Respa-GF
Tablets, sustained release
600 mg
Robitussin
Syrup
100 mg/5 mL
Scot-tussin Expectorant
Syrup
100 mg/5 mL
Sinumist-SR Capsulets
Tablets, sustained release
600 mg
Siltussin SA
Syrup
100 mg/5 mL
Touro Ex
Caplets, sustained release
600 mg
Tussin
Syrup
100 mg/5 mL
Tusibron
Syrup
100 mg/5 mL
Uni-tussin
Syrup
100 mg/5 mL
alminil Expectorant
Benylin E
Class: Expectorant
Drugs Class ::
Action May enhance output of respiratory tract fluid by reducing adhesiveness and surface tension, thus facilitating removal of viscous mucus and making nonproductive coughs more productive and less frequent. Efficacy not well documented.
Indications for Drugs ::
Indications Temporary relief of cough associated with respiratory tract infections and related conditions such as sinusitis, pharyngitis, bronchitis, and asthma when these conditions are complicated by tenacious mucus or mucus plugs and congestion; effective for productive as well as nonproductive cough, particularly dry, nonproductive cough that tends to injure mucous membranes of the air passages.
Drug Dose ::
Route/Dosage
Immediate-release Adults and Children (at least 12 yr): PO 200 to 400 mg q 4 hr (max, 2.4 g/day).
Children (6 to 12 yr): PO 100 to 200 mg q4 hr (max, 1.2 g/day).
Children (2 to 6 yr): PO 50 to 100 mg q 4 hr (max, 600 mg/day).
Children (6 mo to under 2 yr): PO Individualize dose, 25 to 50 mg q 4 hr (max, 300 mg/day).
Sustained- or Extended-release Adults and children (at least 12 yr): PO 575 mg to 1.2 g q 12 hr (max, 2.4 g/day).
Children (6 to 12 yr): PO 575 to 600 mg q 12 hr (max, 1.2 g/day).
Children (2 to 6 yr): PO 275.5 to 300 mg q 12 hr (max, 600 mg/day).
Contraindication ::
Contraindications Standard considerations.
Drug Precautions ::
Precautions
Pregnancy: Category C. Lactation: Undetermined. Persistent cough: May indicate serious condition. Notify physician, pharmacist, or nurse if cough persists for more than 1 wk, tends to recur or is accompanied by high fever, rash, or persistent headache.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CNS: Dizziness; headache. DERMATOLOGIC: Rash; urticaria. GI: Nausea; vomiting.
Drug Mode of Action ::
Action May enhance output of respiratory tract fluid by reducing adhesiveness and surface tension, thus facilitating removal of viscous mucus and making nonproductive coughs more productive and less frequent. Efficacy not well documented.
Drug Interactions ::
Interactions
None well documented.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies.
- Assess lung sounds, cough, sputum production, and color.
- Maintain fluid intake to 2000 mL/day if no contraindications exist.
- Notify health care provider if these signs occur: high fever, rash, or headaches; persistent cough.
Drug Storage/Management ::
Administration/Storage
- Follow administration with glass of water.
- Store at room temperature.
Drug Notes ::
Patient/Family Education
- Explain importance of maintaining increased fluid intake.
- Explain that expectorants are not recommended for some chronic cough conditions, such as cough associated with smoking, emphysema, and asthma.
- Instruct patient to report these symptoms to health care provider: Cough persisting for more than 1 wk or if recurring or accompanied by high fever, rash, or headache.